PMC:7294857 / 9294-9641
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T50 | 74-82 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T51 | 205-214 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T36 | 104-123 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
T37 | 104-113 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T38 | 114-123 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T17 | 207-216 | Phenotype | denotes | eumonia-r | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T78 | 0-284 | Sentence | denotes | Wang, Chao, et al. (2020) Case series Four patients with mild or severe COVID-19 improved after using lopinavir/ritonavir combination. Three out of four patients improved clinically, especially their pneumonia-related symptoms, whereas others also showed significant improvement. |
T79 | 285-347 | Sentence | denotes | More studies, however, are needed to establish their efficacy. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
203 | 45-53 | Species | denotes | patients | Tax:9606 |
204 | 158-166 | Species | denotes | patients | Tax:9606 |
207 | 104-123 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
218 | 74-82 | Disease | denotes | COVID-19 | MESH:C000657245 |
219 | 205-214 | Disease | denotes | pneumonia | MESH:D011014 |